Dr. Julie A. Margenthaler MD
Oncologist | Medical Oncology
660 South Euclid Avenue Campus Box 8109 St. Louis Missouri, 63110Rating
5/5
About
Julie A. Margenthaler, MD, FACS, works at Washington University St. Louis in St. Louis, Missouri. An Associate Professor at the University, Dr. Margenthaler specializes in breast oncology, particularly breast cancer in those younger than 40. Author of over 20 journal articles on this topic and more, Dr. Margenthaler also serves Barnes Jewish Hospital and their affiliates.
Education and Training
Southern Illinois University School of Medicine
Southern Il Univ Sch Of Med- Springfield Il 1997
Board Certification
General Surgery
SurgeryAmerican Board of SurgeryABS
Provider Details
Expert Publications
Data provided by the National Library of Medicine- The resistance of P. acnes--primed interferon gamma-deficient mice to low-dose lipopolysaccharide-induced acute liver injury.
- CD1-dependent natural killer (NK1.1(+)) T cells are required for oral and portal venous tolerance induction.
- Transfer of "infectious" cardiac allograft tolerance induced by donor-specific transfusion.
- Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
- Development of infectious tolerance after donor-specific transfusion and rat
- Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
- Donor-specific antigen transfusion-mediated skin-graft tolerance results from the peripheral deletion of donor-reactive CD8+ T cells.
- Effects of endotoxin tolerance on Propionibacterium acnes-primed lipopolysaccharide hepatic injury.
- "Infectious tolerance" develops after the spontaneous acceptance of Lewis-to-Dark Agouti rat liver transplants.
- Peripheral tolerance in transgenic mice expressing class I MHC L(d) only on cardiac cells.
- Oral and portal venous tolerance in the interferon-gamma knockout (GKO) mouse.
- The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C
- Regional oral tolerance in transgenic 2C mice.
- Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data.
- Metastatic disease to the breast: the Washington University experience.
Clinical Trials
- Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy
- PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery
- Compare Outcomes Between Two Acellular Dermal Matrices
- LS301 Uptake in Tumors of Patients Undergoing Partial Mastectomy and Sentinel Lymph Node Biopsy for Breast Cancer
- Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
- Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy
- Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity
- PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
- Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
Areas of expertise and specialization
Awards
- James Ewing Foundation grant, Society of Surgical Oncology (2006-2007)
- 2006-2007 James Ewing Foundation grant, Society of Surgical Oncology
- 2000-2002 SUS/Ethicon Research Award
- 2000-2001 ALF Postdoctoral Fellowship Award
- 2004 Resident Teaching Award
Treatments
- Breast Cancer, Breast Surgery, Breast Issues
Fellowships
- Research, Washington University School of Medicine, St. Louis MO 2002
- Breast Disease, Washington University School of Medicine, St. Louis MO 2006
Fellowships
- Washington University School of Medicine (Breast disease)
Professional Society Memberships
- American Medical Association, Association of Woman Surgeons, American Society of Clinical Oncology, American Society of Breast Surgeons, St. Louis Surgical Society
What do you attribute your success to?
- Having the Best Training and Working at a Facility with Terrific Treatment Centers and Resources
Hobbies / Sports
- Boating, Baseball, Live Music, Travel
Favorite professional publications
- Journal of Clinical Oncology, Annals of Surgical Oncology
Dr. Julie A. Margenthaler MD's Practice location
St. Louis, Missouri 63110Get Direction
Practice At 216 S Kingshighway Blvd
216 S Kingshighway Blvd -Saint Louis, MO 63110Get Direction
Dr. Julie A. Margenthaler MD's reviews
Write ReviewPatient Experience with Dr. Margenthaler
Recommended Articles
![]()
How Common is Testicular Cancer?Testicular cancer is a form of cancer which affects the male testes or sex glands encased within the scrotum, a loose sac of tissue that hangs freely below the penis. Germ cells are specialized cells lining several heavily coiled tubular structures within the testes that are responsible for...
![]()
$5.8 Million Grant Given to Develop New Immunotherapy for Ovarian CancerOvarian cancer cells can be extremely tricky to get rid of, which makes treatment often expensive and prolonged. Researchers at the University of California San Diego recently received a 5.8-million-dollar grant from the state to develop a new form of immunotherapy for ovarian cancer.The StudyThe...
![]()
New Clinical Trial: Genetically Enhanced Immune Cells for Lymphoma TreatmentB-cell cancers, or cancers that target B-lymphocytes, have been particularly hard to treat in recent years. Recent breakthroughs have led to the conclusion that B-cell cancer can be effectively combated with the use of programmed immune cells.How it WorksThe immune system creates cells that are able...
![]()
Treatments for LeukemiaWhen selecting a cure for blood cancer, one does not decide haphazardly. Thorough research about the background of the type of treatment you are looking into should be conducted. It is also salient to know the effects of the various options so as to prepare the client and the relatives about the...
![]()
Leukopenia: Symptoms, Causes, and TreatmentWhat is leukopenia?White blood cells (WBCs) are an important part of the immune system, which is why they are called as "fighter cells". There are five different types of white blood cells (WBCs) in our body. They are neutrophils, eosinophils, basophils, monocytes, and lymphocytes. Each type of WBC...
![]()
Holistic Treatments for Liver CancerHolistic treatment for liver cancer indicates a science of healing that uses the person's whole spirit, mind and body. This treatment practice integrates the alternative and conventional therapies used to prevent and treat liver cancer, as well as promote the patient's wellbeing. The principle...
Nearby Providers
![]()
Dr. Carl Freter MD3655 Vista Ave St Louis MO 63110![]()
Dr. Elaine Majerus MD1 Barnes Jewish Hospital Plz Saint Louis MO 63110![]()
Dr. Alaa A. Elbendary M.D.11652 Studt Ave Saint Louis MO 63141![]()
Dr. Foluso Olabisi Ademuyiwa MD4921 PARKVIEW PL SAINT LOUIS MO 63110![]()
Dr. Susan L Luedke M.D.6435 Chippewa St Saint Louis MO 63109![]()
Mateusz Opyrchal MD PHD4921 PARKVIEW PL SAINT LOUIS MO 63110
Nearest Hospitals
ST LOUIS CHILDRENS HOSPITALl
ONE CHILDRENS PLACE SAINT LOUIS MO 63110SHRINERS HOSPITALS FOR CHILDRENl
4400 CLAYTON AVE SAINT LOUIS MO 63110ST LOUIS CHILDRENS HOSPITALl
ONE CHILDRENS PLACE SAINT LOUIS MO 63110SHRINERS HOSPITALS FOR CHILDRENl
4400 CLAYTON AVE SAINT LOUIS MO 63110